Sources | Names Used |
---|---|
CTRPv2 | tretinoin:navitoclax (4:1 mol/mol) |
PharmacoGx | tretinoin:navitoclax (4:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C14orf180 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FGD6 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
mRNA | ATCAY | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MMADHC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | KCNE5 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ATP9B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | FREM2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ADD2 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | TTC39B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ZNF573 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |